Life Sciences Market - Industry overview, Trends & Report

sale

Histone Deacetylase Inhibitors Market

U

2026

Histone Deacetylase Inhibitors Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Increasing cancer incidences, ongoing research and development on HDAC inhibitors for the treatment of cancer and other diseases, and the potential of HDAC inhibitors to improve the effectiveness ...

Report Code : A00003 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Enzyme Inhibitors Market

U

2026

Enzyme Inhibitors Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Enzyme inhibitors are naturally occurring molecules that attach to the enzymes to inhibit the culture of harmful pathogens and enhance metabolism. They have varied applications as drugs in ...

Report Code : A01550 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market

U

2026

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes. These inhibitors function by increasing incretin levels which in turn increases insulin secretion, thus decreasing blood glucose levels.

Report Code : A03280 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Immune Checkpoint Inhibitors Market

P

2023

Immune Checkpoint Inhibitors Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global immune checkpoint inhibitors market was valued at $40.1 billion in 2022, and is projected to reach $189.4 billion by 2032, growing at a CAGR of 16.8% from 2023 to 2032.

Report Code : A03382 | Pages : 248 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Beta-lactam and Beta-lactamase Inhibitors Market

P

2019

Beta-lactam and Beta-lactamase Inhibitors Market: Global Opportunity Analysis and Industry Forecast, 2019–2028

The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028.

Report Code : A05062 | Pages : 309 | Category : Life Sciences

Price:

~~$3,456~~ $2,108 (39% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Interleukin Inhibitors Market

U

2026

Interleukin Inhibitors Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Interleukins areglycoproteins that belong to the group of cytokines. Most of the interleukins are synthesized by helper CD4 T lymphocytes, as well as through monocytes, macrophages, and endothelial ...

Report Code : A06189 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Tumor Necrosis Factor Inhibitor Market

U

2026

Tumor Necrosis Factor Inhibitor Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

A Tumor Necrosis Factor inhibitor is a pharmaceutical drug used to destroy the physiologic response to tumor necrosis factor such as inflammatory response caused by TNF cytokines. A ...

Report Code : A10441 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Angiogenesis Inhibitor and Simulator Market

U

2026

Angiogenesis Inhibitor and Simulator Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Angiogenesis is the process of formation or regeneration of new blood vessels out of older ones. It involves migration, differentiation, and subsequent growth of endothelial cells, which are ...

Report Code : A12462 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

North America Immune Checkpoint Inhibitors Market

P

2024

North America Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The current North America Immune Checkpoint Inhibitors Market is quantitatively analyzed from 2022 to 2032 to benchmark the financial competency.

Report Code : * A309118 | Pages : 102 | Category : Life Sciences

Price:

~~$2,850~~ $1,995 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Canada Immune Checkpoint Inhibitors Market

P

2024

Canada Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

By end user, the Canada Immune Checkpoint Inhibitors Market market is bifurcated into various sectors, Of those, Application was the largest segment and captured considerable market share in 2022.

Report Code : * A309119 | Pages : 72 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Immune Checkpoint Inhibitors Market

P

2024

U.S. Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

U.S. Immune Checkpoint Inhibitors Market size is estimated to grow at a significant rate during 2022 to 2032. The U.S. Immune Checkpoint Inhibitors Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.

Report Code : * A309120 | Pages : 82 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Mexico Immune Checkpoint Inhibitors Market

P

2024

Mexico Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

Leading players in Mexico Immune Checkpoint Inhibitors Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.

Report Code : * A309121 | Pages : 74 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Europe Immune Checkpoint Inhibitors Market

P

2024

Europe Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Europe Immune Checkpoint Inhibitors Market is anticipated to expand at a promising CAGR during the forecast period. The Europe Immune Checkpoint Inhibitors Market market achieved significant revenue share in base year of analysis and is expected to remain dominant through the estimated period.

Report Code : * A309122 | Pages : 101 | Category : Life Sciences

Price:

~~$2,850~~ $1,995 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

UK Immune Checkpoint Inhibitors Market

P

2024

UK Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Application in UK Immune Checkpoint Inhibitors Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

Report Code : * A309123 | Pages : 76 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

France Immune Checkpoint Inhibitors Market

P

2024

France Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

Application segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the France Immune Checkpoint Inhibitors Market due to the outbreak of COVID-19.

Report Code : * A309124 | Pages : 81 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Germany Immune Checkpoint Inhibitors Market

P

2024

Germany Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Germany Immune Checkpoint Inhibitors Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The Germany Immune Checkpoint Inhibitors Market growth is attributed to various driving factors and revenue opportunities.

Report Code : * A309125 | Pages : 81 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Asia-Pacific Immune Checkpoint Inhibitors Market

P

2024

Asia-Pacific Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

By component, the Lung Cancer was the dominant sub-segment with major market share in 2022 in the Asia-Pacific Immune Checkpoint Inhibitors Market. This sub-segment is likely to follow same momentum by the end of 2032.

Report Code : * A309126 | Pages : 103 | Category : Life Sciences

Price:

~~$2,670~~ $1,869 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Japan Immune Checkpoint Inhibitors Market

P

2024

Japan Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Application in Japan Immune Checkpoint Inhibitors Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

Report Code : * A309127 | Pages : 86 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

China Immune Checkpoint Inhibitors Market

P

2024

China Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The China Immune Checkpoint Inhibitors Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The China Immune Checkpoint Inhibitors Market growth is attributed to various driving factors and revenue opportunities.

Report Code : * A309128 | Pages : 89 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

India Immune Checkpoint Inhibitors Market

P

2024

India Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The report focuses on the major industry players operating in the India Immune Checkpoint Inhibitors Market and their relative market share. Application segment dominates the India Immune Checkpoint Inhibitors Market and is expected to retain its dominance throughout the forecast period.

Report Code : * A309129 | Pages : 89 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Australia Immune Checkpoint Inhibitors Market

P

2024

Australia Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Application in Australia Immune Checkpoint Inhibitors Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

Report Code : * A309130 | Pages : 74 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

South Korea Immune Checkpoint Inhibitors Market

P

2024

South Korea Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The Application dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.

Report Code : * A309131 | Pages : 89 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

LAMEA Immune Checkpoint Inhibitors Market

P

2024

LAMEA Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

The LAMEA Immune Checkpoint Inhibitors Market is expected to witness strong growth during the forecast period.

Report Code : * A309132 | Pages : 103 | Category : Life Sciences

Price:

~~$2,670~~ $1,869 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Brazil Immune Checkpoint Inhibitors Market

P

2024

Brazil Immune Checkpoint Inhibitors Market: Opportunity Analysis and Industry Forecast, 2022-2032

Application segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Brazil Immune Checkpoint Inhibitors Market due to the outbreak of COVID-19.

Report Code : * A309133 | Pages : 83 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Life Sciences

Filter by Region

Filter by Discounts

Filter by Category

Increasing cancer incidences, ongoing research and development on HDAC inhibitors for the treatment of cancer and other diseases, and the potential of HDAC inhibitors to improve the effectiveness ...

Enzyme inhibitors are naturally occurring molecules that attach to the enzymes to inhibit the culture of harmful pathogens and enhance metabolism. They have varied applications as drugs in ...

Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes. These inhibitors function by increasing incretin levels which in turn increases insulin secretion, thus decreasing blood glucose levels.

The global immune checkpoint inhibitors market was valued at $40.1 billion in 2022, and is projected to reach $189.4 billion by 2032, growing at a CAGR of 16.8% from 2023 to 2032.

The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028.

Interleukins areglycoproteins that belong to the group of cytokines. Most of the interleukins are synthesized by helper CD4 T lymphocytes, as well as through monocytes, macrophages, and endothelial ...

A Tumor Necrosis Factor inhibitor is a pharmaceutical drug used to destroy the physiologic response to tumor necrosis factor such as inflammatory response caused by TNF cytokines. A ...

Angiogenesis is the process of formation or regeneration of new blood vessels out of older ones. It involves migration, differentiation, and subsequent growth of endothelial cells, which are ...

The current North America Immune Checkpoint Inhibitors Market is quantitatively analyzed from 2022 to 2032 to benchmark the financial competency.

By end user, the Canada Immune Checkpoint Inhibitors Market market is bifurcated into various sectors, Of those, Application was the largest segment and captured considerable market share in 2022.

Leading players in Mexico Immune Checkpoint Inhibitors Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.

The Europe Immune Checkpoint Inhibitors Market is anticipated to expand at a promising CAGR during the forecast period. The Europe Immune Checkpoint Inhibitors Market market achieved significant revenue share in base year of analysis and is expected to remain dominant through the estimated period.

The Application in UK Immune Checkpoint Inhibitors Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

Application segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the France Immune Checkpoint Inhibitors Market due to the outbreak of COVID-19.

The Germany Immune Checkpoint Inhibitors Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The Germany Immune Checkpoint Inhibitors Market growth is attributed to various driving factors and revenue opportunities.

By component, the Lung Cancer was the dominant sub-segment with major market share in 2022 in the Asia-Pacific Immune Checkpoint Inhibitors Market. This sub-segment is likely to follow same momentum by the end of 2032.

The Application in Japan Immune Checkpoint Inhibitors Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

The China Immune Checkpoint Inhibitors Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The China Immune Checkpoint Inhibitors Market growth is attributed to various driving factors and revenue opportunities.

The report focuses on the major industry players operating in the India Immune Checkpoint Inhibitors Market and their relative market share. Application segment dominates the India Immune Checkpoint Inhibitors Market and is expected to retain its dominance throughout the forecast period.

The Application in Australia Immune Checkpoint Inhibitors Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

The Application dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.

The LAMEA Immune Checkpoint Inhibitors Market is expected to witness strong growth during the forecast period.

Application segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Brazil Immune Checkpoint Inhibitors Market due to the outbreak of COVID-19.